Q3 2023 Holdings
Filed 2023-11-14 | 106 holdings | $708.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $38.0M | 2,140,586 | 5.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $35.9M | 1,137,107 | 5.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $35.0M | 1,950,609 | 4.9% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $33.1M | 3,440,345 | 4.7% |
| Evolus Inc(EOLS) | COM | 30052C107 | $28.3M | 3,097,399 | 4.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $23.8M | 1,500,000 | 3.4% |
| Eqrx Inc | COM | 26886C107 | $22.4M | 10,086,110 | 3.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $22.4M | 320,000 | 3.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $21.1M | 405,600 | 3.0% |
| New York Cmnty Bancorp Inc(NYCBEUR) | COM | 649445103 | $18.2M | 1,606,600 | 2.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $16.1M | 30,000 | 2.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $15.6M | 300,000 | 2.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $15.3M | 300,000 | 2.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $15.3M | 85,000 | 2.2% |
| Bluebird BIO Inc | COM | 09609G100 | $13.0M | 4,282,827 | 1.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $12.7M | 1,800,000 | 1.8% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $12.6M | 397,600 | 1.8% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.5M | 170,000 | 1.6% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $11.5M | 1,800,000 | 1.6% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $10.8M | 3,600,000 | 1.5% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $10.4M | 600,000 | 1.5% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $10.3M | 1,000,000 | 1.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $10.3M | 669,125 | 1.4% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $9.1M | 200,000 | 1.3% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $8.9M | 271,200 | 1.3% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $8.6M | 24,000 | 1.2% |
| Inflarx NV(IFRX) | COM | N44821101 | $8.4M | 2,824,353 | 1.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $8.3M | 6,450,000 | 1.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $8.1M | 591,636 | 1.1% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $7.9M | 492,100 | 1.1% |
| Moderna Inc(MRNA) | COM | 60770K107 | $7.9M | 76,700 | 1.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $7.8M | 180,000 | 1.1% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $7.2M | 891,514 | 1.0% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $7.2M | 2,750,000 | 1.0% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $7.0M | 1,100,000 | 1.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $6.4M | 3,778,393 | 0.9% |
| Uniqure NV(QURE) | SHS | N90064101 | $6.3M | 935,800 | 0.9% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $5.8M | 750,000 | 0.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $5.6M | 621,138 | 0.8% |
| Equity Comwlth(HP5A) | COM SH BEN INT | 294628102 | $5.5M | 300,000 | 0.8% |
| Avrobio Inc | COM | 05455M100 | $5.4M | 3,512,686 | 0.8% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $5.4M | 5,862,517 | 0.8% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $5.0M | 2,016,626 | 0.7% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $4.9M | 1,360,000 | 0.7% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $4.4M | 300,000 | 0.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.2M | 166,203 | 0.6% |
| Citigroup Inc(C) | COM NEW | 172967424 | $4.1M | 100,000 | 0.6% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $4.0M | 5,166,954 | 0.6% |
| Quince Therapeutics Inc(QNCX) | COM | 22053A107 | $3.9M | 3,498,868 | 0.6% |
| Veritex Hldgs Inc(VBTX) | COM | 923451108 | $3.8M | 210,000 | 0.5% |